ArticleFrontiers in oncology2026
Synchronous bilateral phyllodes tumors with discordant grades and false-positive axillary
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rationale: Phyllodes tumors are uncommon fibroepithelial breast neoplasms with variable biologic behavior. Synchronous bilateral phyllodes tumors are exceptionally rare, and the interpretation of Patient concerns: A 44-year-old Korean woman presented with a rapidly enlarging, painful, ulcerated left breast mass for 3 months. She had no nipple discharge, fever, or weight loss. A right breast lesion was clinically occult. Diagnoses: Ultrasound showed a right breast hypoechoic nodule (BI-RADS 4A) with scant vascularity and an elastography score of 2, and a giant heterogeneous hypervascular left breast mass with enlarged axillary lymph nodes and an elastography score of 4. Interventions: After multidisciplinary review, the patient underwent excision of the right breast mass with frozen-section margin assessment, left total mastectomy including the nipple-areola complex and ulcerated skin to achieve negative margins, and level I-II axillary lymph node dissection because sentinel lymph node biopsy was considered unreliable in the setting of massive ulceration and severe axillary edema. Outcomes: Recovery was uneventful. Ceftriaxone sodium 2.0 g was given intravenously once daily from 1 day before surgery through postoperative day 5. No wound infection, seroma, fever, or unexpected adverse events occurred. At 1 month, CA125, CA15-3, and CA19-9 had normalized. Lessons: In phyllodes tumors, marked axillary FDG avidity may reflect reactive inflammation rather than true nodal metastasis, particularly in giant ulcerated tumors with necrosis. Management should emphasize complete excision with negative margins and cautious axillary surgery guided by clinicopathologic correlation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.